Pathophysiology of the no-reflow phenomenon

Acute Cardiac Care

Volumn 11, Issue 2, 2009, Pages 69-76

  Vrints, Christiaan J M ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

endothelium; Myocardial infarction; oxidative stress; post conditioning; reperfusion

Indexed keywords

ARTIFICIAL EMBOLISM; CONFERENCE PAPER; CORONARY ARTERY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; INFLAMMATION; ISCHEMIC POSTCONDITIONING; MICROVASCULATURE; NEUTROPHIL; NO REFLOW PHENOMENON; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REPERFUSION INJURY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBUS; THROMBUS ASPIRATION; ULTRASTRUCTURE; VASOCONSTRICTION; ANIMAL; BLOOD FLOW; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; HEART INFARCTION; METABOLISM; PHYSIOLOGY; PROGNOSIS; REVIEW; RISK FACTOR;

ANIMALS; CORONARY CIRCULATION; CORONARY VESSELS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; OXIDATIVE STRESS; PROGNOSIS; REGIONAL BLOOD FLOW; RISK FACTORS;

EID: 70249139190     PISSN: 17482941     EISSN: 1748295X     Source Type: Journal    
DOI: 10.1080/17482940902978061     Document Type: Conference Paper

References (58)

1. van 't Hof AW, Liem A, de Boer MJ, Zijlstra F. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle myocardial infarction study group. Lancet. 1997;350:615-9. (Pubitemid 27367794)
2. Claeys MJ, Bosmans J, Veenstra L, Jorens P, De Raedt H, Vrints CJ. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: Importance of microvascular reperfusion injury on clinical outcome. Circulation. 1999; 99:1972-7. (Pubitemid 29183893)
3. van 't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: Myocardial blush grade. Zwolle myocardial infarction study group. Circulation. 1998; 97:2302-6. (Pubitemid 28280383)
4. Stone GW, Peterson MA, Lansky AJ, Dangas G, Mehran R, Leon MB. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol. 2002;39:591-7. (Pubitemid 34158153)
5. Kloner RA, Ganote CE, Jennings RB. The 'no-reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974;54:1496-508.
6. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, et al. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 1996;93:223-8. (Pubitemid 26031478)
7. Bolognese L, Carrabba N, Parodi G, Santoro GM, Buonamici P, Cerisano G, et al. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation. 2004;109:1121-6. (Pubitemid 38332616)
8. Kloner RA, Rude RE, Carlson N, Maroko PR, DeBoer LW, Braunwald E. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: Which comes first? Circulation. 1980;62:945-52. (Pubitemid 11225959)
9. Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation. 1989;80:1846-61. (Pubitemid 20031716)
10. Reffelmann T, Kloner RA. Microvascular reperfusion injury: Rapid expansion of anatomic no reflow during reperfusion in the rabbit. Am J Physiol Heart Circ Physiol. 2002;283:H1099-107.
11. Engler RL, Schmid-Schonbein GW, Pavelec RS. Leukocyte capillary plugging in myocardial ischaemia and reperfusion in the dog. Am J Pathol. 1983;111:98-111. (Pubitemid 13117180)
12. Braunwald E, Kloner RA. Myocardial reperfusion: A doubleedged sword? J Clin Invest. 1985;76:1713-9.
13. Garcia-Dorado D, Piper HM. Postconditioning: Reperfusion of 'reperfusion injury' after hibernation. Cardiovasc Res. 2006;69:1-3.
14. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285:H579-88. (Pubitemid 36885888)
15. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I, et al. Postconditioning the human heart. Circulation. 2005; 112:2143-8. (Pubitemid 41475808)
16. Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, Rioufol G, et al. Long-term benefit of postconditioning. Circulation. 2008;117:1037-44.
17. Moens AL, Claeys MJ, Timmermans JP, Vrints CJ. Myocardial ischaemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol. 2005;100:179-90.
18. Monassier J-P. Reperfusion injury in acute myocardial infarction: From bench to cath lab. Part II: Clinical issues and therapeutic options. Arch Cardiovasc Dis. 2008;101:565-75.
19. Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA. 1987;84:1404-7. (Pubitemid 17027362)
20. Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J, Hoppel CL. Mitochondrial dysfunction in cardiac disease: Ischaemia- reperfusion, aging, and heart failure. J Mol Cell Cardiol. 2001;33:1065-89. (Pubitemid 32579276)
21. Jezek P, Hlavatá L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int J Biochem & Cell Biol. 2005;37:2478-503. (Pubitemid 41400319)
22. Zweier JL, Talukder MAH. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res. 2006;70: 181-90.
23. VanBenthuysen KM, McMurtry IF, Horwitz LD. Reperfusion after acute coronary occlusion in dogs impairs endothelium- dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J Clin Invest. 1987;79:265-74. (Pubitemid 17232527)
24. Lefer AM, Tsao PS, Lefer DJ, Ma XL. Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischaemia. FASEB J. 1991;5:2029-34. (Pubitemid 121000166)
25. Vrints CJ, Bult H, Bosmans J, Herman AG, Snoeck JP. Paradoxical vasoconstriction as result of acetylcholine and serotonin in diseased human coronary arteries. Eur Heart J. 1992;13:824-31.
26. Niccoli G, Giubilato S, Russo E, Spaziani C, Leo A, Porto I, et al. Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention. Eur Heart J. 2008;29:1843-50.
27. Schmidt TS, Alp NJ. Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease. Clin Sci (Lond). 2007;113:47-63. (Pubitemid 47066025)
28. Vasquez-Vivar J, Kalyanaraman B, MartÃsek P, Hogg N, Masters BSS, Karoui H, et al. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors. Proc Natl Acad Sci USA. 1998;95:9220-5. (Pubitemid 28506212)
29. Wever RMF, Luscher TF, Cosentino F, Rabelink TJ. Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation. 1998;97:108-12. (Pubitemid 28036161)
30. Alp NJ, Channon KM. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol. 2004;24:413-20. (Pubitemid 38326132)
31. Forstermann U, Munzel T. Endothelial nitric oxide synthase in vascular disease: From marvel to menace. Circulation. 2006;113:1708-14.
32. Moens AL, Champion HC, Claeys MJ, Tavazzi B, Kaminski PM, Wolin MS, et al. High-dose folic acid pretreatment blunts cardiac dysfunction during ischaemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury. Circulation. 2008;117:1810-9. (Pubitemid 351507469)
33. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res. 2004;61:481-97. (Pubitemid 38210154)
34. Piper HM, Garcna-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res. 1998;38:291-300. (Pubitemid 28294147)
35. Ladilov Y, Efe Ö, Schäfer C, Rother B, Kasseckert S, Abdallah Y, et al. Reoxygenation-induced rigor-type contracture. J Mol Cell Cardiol. 2003;35:1481-90.
36. Piper HM, Kasseckert S, Abdallah Y. The sarcoplasmic reticulum as the primary target of reperfusion protection. Cardiovasc Res. 2006;70:170-3.
37. Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM. Inhibiting mitochondrial permeability transition pore opening: A new paradigm for myocardial preconditioning? Cardiovasc Res. 2002;55:534-43. (Pubitemid 34874948)
38. Hausenloy DJ, Yellon DM. The mitochondrial permeability transition pore: Its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol. 2003;35:339-41. (Pubitemid 36411694)
39. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion*a target for cardioprotection. Cardiovasc Res. 2004;61:372-85. (Pubitemid 38210145)
40. Halestrap AP. Calcium, mitochondria and reperfusion injury: A pore way to die. Biochem Soc Trans. 2006;34:232-7.
41. Halestrap AP. What is the mitochondrial permeability transition pore? J Mol Cell Cardiol. in press.
42. Halestrap AP, Pasdois P. The role of the mitochondrial permeability transition pore in heart disease. Biochimica et Biophysica Acta (BBA), Bioenergetics. in press.
43. Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med. 2008;359:473-81.
44. Zhao ZQ, Nakamura M, Wang NP, Velez DA, Hewan-Lowe KO, Guyton RA, et al. Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion. J Surg Res. 2000;94:133-44.
45. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. 2000;101:570-80. (Pubitemid 30080873)
46. Henriques JPS, Zijlstra F, Ottervanger JP, de Boer MJ, van 't Hof AWJ, Hoorntje JCA, et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J. 2002;23: 1112-7. (Pubitemid 35230716)
47. Fokkema ML, Vlaar PJ, Svilaas T, Vogelzang M, Amo D, Diercks GF, et al. Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction. Eur Heart J. 2009;.
48. Saber RS, Edwards WD, Bailey KR, McGovern TW, Schwartz RS, Holmes DR, Jr. Coronary embolization after balloon angioplasty or thrombolytic therapy: An autopsy study of 32 cases. J Am Coll Cardiol. 1993;22:1283-8. (Pubitemid 23316347)
49. Okamura A, Ito H, Iwakura K, Kurotobi T, Koyama Y, Date M, et al. Clinical implications of distal embolization during coronary interventional procedures in patients with acute myocardial infarction: Quantitative study with doppler guidewire. J Am Coll Cardiol Interv. 2008;1:268-76. (Pubitemid 351804188)
50. Kawaguchi R, Oshima S, Jingu M, Tsurugaya H, Toyama T, Hoshizaki H, et al. Usefulness of virtual histology intravascular ultrasound to predict distal embolization for STsegment elevation myocardial infarction. J Am Coll Cardiol. 2007;50:1641-6. (Pubitemid 47562679)
51. De Luca G, Suryapranata H, Stone GW, Antoniucci D, Neumann F-J, Chiariello M. Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarc- tion: A meta-analysis of randomized trials. Am Heart J. 2007;153:343-53. (Pubitemid 46328758)
52. Burzotta F, Testa L, Giannico F, Biondi-Zoccai GGL, Trani C, Romagnoli E, et al. Adjunctive devices in primary or rescue PCI: A meta-analysis of randomized trials. Int J Cardiol. 2008;123:313-21. (Pubitemid 350297454)
53. Svilaas T, Vlaar PJ, van der Horst IC, Diercks GFH, de Smet BJGL, van den Heuvel AFM, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008;358:557-67. (Pubitemid 351214283)
54. Vlaar PJ, Svilaas T, van der Horst IC, Diercks GFH, Fokkema ML, de Smet BJGL, et al. Cardiac death and reinfarction after 1 year in the thrombus aspiration during percutaneous coronary intervention in acute myocardial infarction study (TAPAS): A 1-year follow-up study. Lancet. 2008;371:1915-20. (Pubitemid 351778190)
55. Burzotta F, Crea F. Thrombus-aspiration: A victory in the war against no reflow. Lancet. 2008;371:1889-90. (Pubitemid 351778171)
56. Abbate A, Kontos MC, Biondi-Zoccai GGL. No-reflow: The next challenge in treatment of ST-elevation acute myocardial infarction. Eur Heart J. 2008;29:1795-7.
57. Steg PG, Ducrocq G. Devices to protect against embolization during primary angioplasty for ST-segment elevation myocardial infarction: The good, the bad and the ugly. Eur Heart J. 2008;29:2953-4.
58. Yellon DM, Hausenloy DJ. Realizing the clinical potential of ischemic preconditioning and postconditioning. Nat Clin Pract Cardiovasc Med. 2005;2:568-75. (Pubitemid 41655660)